全球生物安全检测产品和服务市场规模、份额、趋势和成长分析报告（2026-2034年）

预计生物安全检测产品和服务的市场规模将从 2025 年的 62.3 亿美元成长到 2034 年的 158.9 亿美元，2026 年至 2034 年的复合年增长率为 10.97%。

对安全生物製药和疫苗日益增长的需求正推动全球生物安全检测产品和服务市场显着成长。监管机构要求对包括疫苗、细胞疗法和单株抗体在内的生物製药进行严格的安全检测，这促进了先进检测服务和产品的应用。生物技术领域研究活动的增加和製药生产设施的扩张也进一步支撑了市场成长。

此外，全球生物製药和生物相似药研发管线的不断增长也为市场发展提供了利好。随着越来越多的生物製药进入临床试验，对污染检测、内毒素检测和无菌检测的需求日益增长。快速微生物检测方法和自动化检测解决方案的技术进步正在提高检测的准确性和效率。製药和生物技术公司正在加速采用创新检测平台，以确保产品品质和符合法规要求。

展望未来，随着生物製药和先进治疗方法继续主导製药业，市场预计将保持强劲成长。受託研究机构（CRO）和实验室的扩张将进一步加速外包趋势。此外，新兴市场对製药生产基础设施的投资增加，也为生物安全检测服务创造了新的机会。检测技术的持续创新和严格的监管标准将继续成为影响未来成长的关键因素。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球生物安全检测产品与服务市场：依产品类别划分

• 市场分析、洞察与预测
• 试剂和试剂盒
• 装置
• 服务

第五章 全球生物安全检测产品与服务市场：依应用领域划分

• 市场分析、洞察与预测
• 疫苗及治疗药物（疫苗、单株抗体、重组蛋白）
• 血液及血液製品
• 基因治疗
• 组织和源自组织的商品
• 干细胞

第六章 全球生物安全检测产品与服务市场：依检测类型划分

• 市场分析、洞察与预测
• 内毒素试验
• 无菌测试
• 细胞株认证和表征测试
• 微生物附着量测试
• 异物检测测试
• 残留宿主污染检测
• 其他的

第七章 全球生物安全检测产品与服务市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Charles River Laboratories International
  • BSL Bioservice GmbH
  • Merck KGaA（MilliporeSigma）
  • Samsung Biologics Co. Ltd
  • Sartorius AG
  • Eurofins Scientific SE
  • SGS SociAfA（C）TAfA（C）GAfA（C）NAfA（C）Rale De Surveillance SA
  • Thermo Fisher Scientific Inc
  • BioMAfA（C）Rieux SA
  • Lonza Group AG

The Biological Safety Testing Products And Services Market size is expected to reach USD 15.89 Billion in 2034 from USD 6.23 Billion (2025) growing at a CAGR of 10.97% during 2026-2034.

The global biological safety testing products and services market is experiencing significant growth due to the rising demand for safe biopharmaceutical products and vaccines. Regulatory authorities require strict safety testing for biologics, including vaccines, cell therapies, and monoclonal antibodies, which is driving the adoption of advanced testing services and products. Increasing research activities in biotechnology and the expansion of pharmaceutical manufacturing facilities are further supporting market expansion.

The market is also benefiting from the growing pipeline of biologics and biosimilars worldwide. As the number of biologic drugs entering clinical trials increases, the need for contamination testing, endotoxin testing, and sterility testing is rising. Technological advancements in rapid microbiological methods and automated testing solutions are improving testing accuracy and efficiency. Pharmaceutical and biotechnology companies are increasingly adopting innovative testing platforms to ensure product quality and regulatory compliance.

Looking ahead, the market is expected to witness robust growth as biologics and advanced therapies continue to dominate the pharmaceutical landscape. The expansion of contract research organizations and testing laboratories will further boost outsourcing trends. Moreover, emerging markets are investing heavily in pharmaceutical manufacturing infrastructure, creating new opportunities for biological safety testing services. Continuous innovation in testing technologies and stringent regulatory standards will remain key factors shaping future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Reagents & Kits
• Instruments
• Services

By Application

• Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein)
• Blood & Blood-Based Products
• Gene Therapy
• Tissue & Tissue-Based Products
• Stem Cell

By Test Type

• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication & Characterization Tests
• Bioburden Tests
• Adventitious Agent Detection Tests
• Residual Host Contamination Detection Tests
• Others

COMPANIES PROFILED

• Charles River Laboratories International, BSL Bioservice GmbH, Merck KGaA MilliporeSigma, Samsung Biologics Co Ltd, Sartorius AG, Eurofins Scientific SE, SGS Socit Gnrale de Surveillance SA, Thermo Fisher Scientific Inc, bioMrieux SA, Lonza Group AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Blood & Blood-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tissue & Tissue-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Stem Cell Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. Endotoxin Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sterility Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cell Line Authentication & Characterization Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Bioburden Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Adventitious Agent Detection Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Residual Host Contamination Detection Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By Test Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By Test Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By Test Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By Test Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By Test Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Charles River Laboratories International
  • 9.2.2 BSL Bioservice GmbH
  • 9.2.3 Merck KGaA (MilliporeSigma)
  • 9.2.4 Samsung Biologics Co. Ltd
  • 9.2.5 Sartorius AG
  • 9.2.6 Eurofins Scientific SE
  • 9.2.7 SGS SociAfA(C)TAfA(C) GAfA(C)NAfA(C)Rale De Surveillance SA
  • 9.2.8 Thermo Fisher Scientific Inc
  • 9.2.9 BioMAfA(C)Rieux SA
  • 9.2.10 Lonza Group AG